Figure 3

The correlation of signature with tumor mutation burden (TMB) and Gene Ontology Term Enrichment (GO) analysis. Mutation genes in high risk (A) and low risk group (B). (C) Tumor mutation burden in high- and low-risk group. (D) Survival rate in high and low TMB group. (E) Gene Ontology Term Enrichment (GO) analysis. (F) PCR validation in normal ad GBM patient samples.